====== Jeremy Grimshaw ======

{{ ::ohri-profile-j.grimshaw-180x180.jpg?200|}}

Dr. **Jeremy M. Grimshaw**, MBChB, PhD, FRCGP, FCAHS is a Canadian health information specialist and epidemiologist based in [[Canada:ontario:Ottawa]], [[canada:Ontario]].

Grimshaw is a Tier 1 [[Canada Research Chair]] in Health Knowledge Transfer and Uptake.((//Jeremy M. Grimshaw.// (2021, June 25). Government of Canada. https://archive.ph/nAcbI))

===== Education =====

  * Faculty of Medicine, [[University of Edinburgh]], 1979 - 1984
  * Faculty of Medicine, [[University of Aberdeen]], 1989 - 1997

===== Career and Affiliations =====

==== Canadian Academy of Health Sciences ====

Grimshaw is a fellow of the [[Canadian Academy of Health Sciences]].((//Jeremy Grimshaw.// McMaster University Health Forum. Retrieved May 8, 2022, from https://archive.ph/om3b0))

==== University of Ottawa ====

Grimshaw is a professor in the Department of Medicine at the [[University of Ottawa]].((//Grimshaw, Jeremy.// Department of Epidemiology. Retrieved May 8, 2022, from https://archive.ph/eFdqy))

==== Campbell Collaboration ====

Grimshaw is the President of the Board of the Directors of the [[Campbell Collaboration]].((//Campbell Board.// Campbell Collaboration. Retrieved May 8, 2022, from https://archive.ph/FHcwL))

He was initially elected as co-chair in 2016.((//Campbell Collaboration elects Jeremy Grimshaw as new co-Chair.// (2016, April 5). Campbell Collaboration. https://archive.ph/pjlp1))

==== The Ottawa Hospital ====

Grimshaw is a Senior Scientist in the Clinical Epidemiology Program at the [[Ottawa Hospital Research Institute]].((//Jeremy Grimshaw.// Ottawa Hospital Research Institute. Retrieved May 8, 2022, from http://www.ohri.ca/profile/jgrimshaw))

==== Eastern Ontario Regional Laboratory Association ====

Grimshaw sits on the board of directors at the [[Eastern Ontario Regional Laboratory Association]].((//Board of Directors.// Eastern Ontario Regional Laboratory Association. Retrieved May 8, 2022, from https://archive.ph/dHgGJ))

==== AcademyHealth ====

Grimshaw has been a presenter for [[AcademyHealth]].((//Jeremy Grimshaw, MB.Ch.B., Ph.D.// AcademyHealth. Retrieved May 8, 2022, from https://web.archive.org/web/20220508091404/https://academyhealth.org/about/people/jeremy-grimshaw-mbchb-phd))

==== Ontario COVID-19 Science Advisory Table ====

Grimshaw is a member of the Behavioural Science Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/))

===== Research =====

Grimshaw received a strategic grant from the [[Cardiac Arrhythmia Network of Canada]] for a study titled "Decreasing Hospital Admissions from the Emergency Department for Acute Atrial Fibrillation".((Grimshaw, J. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220508082748/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Jeremy-Grimshaw_20210513.pdf)) CANC is partnered with many organizations with interest in [[COVID-19]] including [[pharmaceutical_companies:Apotex]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[IBM]], [[pharmaceutical_companies:Johnson & Johnson]], [[LifeLabs]], [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Pfizer]], and [[pharmaceutical_companies:St. Jude Medical]] (an [[pharmaceutical_companies:Abbott]] company).((//About Us.// (2021, September 28). Cardiac Arrhythmia Network of Canada (CANet). https://canet-nce.ca/about/))

==== COVID-19 ====

Grimshaw is a co-Principal Investigator and co-Chair of the [[COVID-END]] study, funded by the [[Canadian Institutes of Health Research]] (CIHR).((Grimshaw, J. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220508082748/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Jeremy-Grimshaw_20210513.pdf)) He is also a member of the Canadian secretariat.((//Secretariat.// (2021). McMaster Health Forum. https://www.mcmasterforum.org/networks/covid-end/resources-specific-to-canada/about-us/secretariat))

Grimshaw is a co-founder of the [[Behavioural, Environmental, Social and System Interventions Collaboration]] (BESSI), "which aims to promote research into BESSIs to reduce transmission and mitigate the effects of the pandemic."((//About | Behavioural, Environmental, Social and Systems Interventions.//  BESSI-Collab. Retrieved May 8, 2022, from https://www.bessi-collab.net/about-us))

Grimshaw is a co-investigator for the [[Coronavirus Variants Rapid Response Network]] (CoVaRR-Net), funded by the [[Canadian Institutes of Health Research]] (CIHR).((//Our Team.// CoVaRR-Net. Retrieved May 8, 2022, from https://archive.ph/EWWMo))

==== Vaccine hesitancy ====

Grimshaw received funding from the [[Public Health Agency of Canada]] (PHAC) for a study on [[vaccine hesitancy]] related to [[COVID-19 vaccines]].((Crawshaw, J., Konnyu, K., Castillo, G., Zack Van Allen, Mba, M., Grimshaw, J., & Presseau, J. (2021). //Factors affecting COVID-19 vaccination acceptance and uptake among the general public: a living behavioural science evidence synthesis.// McMaster University Health Forum. https://web.archive.org/web/20220509061411/https://www.mcmasterforum.org/docs/default-source/product-documents/living-evidence-syntheses/covid-19-living-evidence-synthesis-4.1---factors-affecting-covid-19-vaccination-acceptance-and-uptake-among-the-general-public.pdf?sfvrsn=5368712f_7))

==== Diabetes ====

Grimshaw received an operating grant from as a co-Principal Investigator from [[Diabetes Action Canada]] for a study called "An implementation
science approach to increase attendance to retinopathy screening by people with [[diabetes]]."((Grimshaw, J. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220508082748/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Jeremy-Grimshaw_20210513.pdf)) DAC is funded by [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Merck]] and [[Sun Life Financial]].((//Strategic Partners.// Diabetes Action Canada - SPOR Network. Retrieved May 8, 2022, from https://archive.ph/upCkV))

==== Antimicrobial Resistance ====

Grimshaw has published research on [[antimicrobial resistance]] with funding by the [[Joint Programming Initiative on Antimicrobial Resistance Network]] (JPIARN).((Rzewuska, M., Charani, E., Clarkson, J. E., Davey, P. G., Duncan, E. M., Francis, J. J., Gillies, K., Kern, W. V., Lorencatto, F., Marwick, C. A., McEwen, J., Möhler, R., Morris, A. M., Ramsay, C. R., Rogers Van Katwyk, S., Skodvin, B., Smith, I., Suh, K. N., & Grimshaw, J. M. (2019). //Prioritizing research areas for antibiotic stewardship programmes in hospitals: a behavioural perspective consensus paper.// Clinical Microbiology and Infection, 25(2), 163–168. https://doi.org/10.1016/j.cmi.2018.08.020))
==== Awards and Recognition ====

Grimshaw was recognized as a [[Thomson Reuters]] Highly Cited Researcher in 2015, 2016 2017 and 2018.((//ICES scientists Peter Austin and Jeremy Grimshaw selected as 2016 Thomson Reuters Highly Cited Researchers.// (2016, November 18). ICES. https://archive.ph/ieRPL)) ((Grimshaw, J. M. (2019, June 3). //Curriculum Vitae.// McMaster University Health Forum. https://web.archive.org/web/20220509011301/https://www.mcmasterforum.org/docs/default-source/people-cv/grimshaw-cv.pdf?sfvrsn=53d154d5_3))